AU2003246143A1 - Polypeptide agent for inhibiting sars coronavirus and its derivatives and use thereof - Google Patents

Polypeptide agent for inhibiting sars coronavirus and its derivatives and use thereof

Info

Publication number
AU2003246143A1
AU2003246143A1 AU2003246143A AU2003246143A AU2003246143A1 AU 2003246143 A1 AU2003246143 A1 AU 2003246143A1 AU 2003246143 A AU2003246143 A AU 2003246143A AU 2003246143 A AU2003246143 A AU 2003246143A AU 2003246143 A1 AU2003246143 A1 AU 2003246143A1
Authority
AU
Australia
Prior art keywords
derivatives
sars coronavirus
polypeptide agent
inhibiting sars
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003246143A
Inventor
George F. Gao
Bo Tian
Gengfu Xiao
Congyi Zheng
Jieqing Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan University WHU
Institute of Microbiology of CAS
Original Assignee
Wuhan University WHU
Institute of Microbiology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan University WHU, Institute of Microbiology of CAS filed Critical Wuhan University WHU
Publication of AU2003246143A1 publication Critical patent/AU2003246143A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2003246143A 2003-05-16 2003-06-12 Polypeptide agent for inhibiting sars coronavirus and its derivatives and use thereof Abandoned AU2003246143A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN03136220.6 2003-05-16
CNB031362206A CN1223605C (en) 2003-05-16 2003-05-16 Polypeptide medicine for inhibiting SARS coronavirus, and derivatives and use thereof
PCT/CN2003/000457 WO2005080419A1 (en) 2003-05-16 2003-06-12 Polypeptide agent for inhibiting sars coronavirus and its derivatives and use thereof

Publications (1)

Publication Number Publication Date
AU2003246143A1 true AU2003246143A1 (en) 2005-09-05

Family

ID=34154758

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003246143A Abandoned AU2003246143A1 (en) 2003-05-16 2003-06-12 Polypeptide agent for inhibiting sars coronavirus and its derivatives and use thereof

Country Status (3)

Country Link
CN (1) CN1223605C (en)
AU (1) AU2003246143A1 (en)
WO (1) WO2005080419A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491489B2 (en) * 2004-11-22 2009-02-17 The University Of Hong Knog Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof
CN100339396C (en) * 2005-04-18 2007-09-26 中国科学院微生物研究所 Multi-helix protein for inhibiting membrane virus infection, its coding gene and use
US8470771B2 (en) 2007-11-14 2013-06-25 Institute Of Microbiology, Chinese Academy Of Sciences Method and medicament for inhibiting the infection of influenza virus
CN101186637B (en) * 2007-11-14 2011-09-14 中国科学院微生物研究所 Method for inhibiting influenza virus infection and medicament thereof
CN107245095B (en) * 2017-06-15 2020-05-26 武汉大学 Polypeptide inhibitor for inhibiting ten kinds of coronavirus
CN113264990B (en) * 2020-02-14 2022-09-27 深圳大学 Polypeptide for inhibiting novel coronavirus (SARS-COV-2) and application thereof
CN111349150B (en) * 2020-03-24 2021-02-09 北京中科微盾生物科技有限责任公司 Polypeptide for inhibiting novel coronavirus and application thereof
CN111518163B (en) * 2020-04-08 2022-04-12 大连百奥泰科技有限公司 Application of lipopeptide compounds in resisting novel coronavirus
CN111647048B (en) * 2020-06-22 2021-04-02 中国科学院昆明动物研究所 Application of interference polypeptide in preparing anti-SARS-CoV-2 medicine
JP7231745B2 (en) * 2020-06-22 2023-03-01 中国科学院昆明▲動▼物研究所 Application of Interfering Polypeptides in the Preparation of Anti-SARS-CoV-2 Drugs
US10906944B2 (en) * 2020-06-29 2021-02-02 The Scripps Research Institute Stabilized coronavirus spike (S) protein immunogens and related vaccines
US11479582B2 (en) 2020-10-16 2022-10-25 King Faisal University Anti-SARS-CoV-2 fusion peptides
CA3231587A1 (en) * 2021-09-08 2023-03-16 Dana-Farber Cancer Institute, Inc. Antiviral structurally-stapled sars-cov-2 peptide- cholesterol conjugates and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2316681B (en) * 1993-09-16 1998-04-15 Dimminaco Ag Sa Ltd Antigenically active proteins/polypeptides and coronavirus vaccines containing the same
WO1998049195A1 (en) * 1997-04-29 1998-11-05 Universiteit Utrecht Corona virus-like particles as tools for vaccination and therapy
US6623741B1 (en) * 2000-02-29 2003-09-23 Trimeris, Inc. Methods and compositions for inhibition of membrane fusion-associated events including RSV transmission
WO2001074295A2 (en) * 2000-03-31 2001-10-11 The Scripps Research Institute Phospholipid scramblases and methods of use thereof

Also Published As

Publication number Publication date
WO2005080419A1 (en) 2005-09-01
CN1488641A (en) 2004-04-14
CN1223605C (en) 2005-10-19

Similar Documents

Publication Publication Date Title
AU2003263345A1 (en) Sulphonamide derivatives and their use as tace inhibitors
AU2003266321A1 (en) Tetrahydropyrimidine-2-one derivatives and their uses
IL178297A0 (en) Hydrazide derivatives and pharmaceutical compositions containing the same
IL162548A0 (en) 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same
IL164209A0 (en) Pyrazole derivatives and pharmaceutical compositions containing the same
IL166620A0 (en) Pyrazole derivatives and pharmaceutical compositions containing the same
IL166482A0 (en) Dihydropyrazolopyridine derivatives and pharmaceutical compositions containing the same
IL173602A0 (en) Heteroarylaminosulfonylphenyl derivatives and pharmaceutical compositions containing the same
IL173627A0 (en) 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives and pharmaceutical compositions containing the same
IL173051A0 (en) N-glucoside derivatives and pharmaceutical compositions containing the same
AU2003262262A1 (en) Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof
IL171997A0 (en) Pyrrolodihydroisoquinoline derivatives and pharmaceutical compositions containing the same
IL175214A0 (en) 2-cyanopyrrolidinecarboxamide derivatives and pharmaceutical compositions containing the same
IL164987A (en) Proline derivatives and pharmaceutical compositions containing the same
IL172159A0 (en) 2-oxo-pyridine derivatives and pharmaceutical compositions containing the same
IL177168A0 (en) N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same
IL177073A0 (en) Hydroxy-6-heteroarylphenanthridine derivatives and pharmaceutical compositions containing the same
AU2003254844A1 (en) Substituted amino compounds and use thereof
AU2003303388A1 (en) Triptolide derivatives and their use
AU2002364051A1 (en) Anti-cancer combination and use thereof
IL163868A0 (en) Hermiasterlin derivatives and uses thereof
AU2003246143A1 (en) Polypeptide agent for inhibiting sars coronavirus and its derivatives and use thereof
AU2003291443A1 (en) Compositions and processes for nanoimprinting
AU2003266254A1 (en) Device for positional and/or length determination
PL374581A1 (en) Diaminothiazoles and use thereof as cdk4 inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase